Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BMXMFOTCMKTS:MAURYOTCMKTS:NPNYYOTCMKTS:RNLSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMXMFbioMérieux$131.01$125.29$93.50▼$131.75$15.51B0.741,417 shsN/AMAURYMarui Group$39.00-2.0%$37.77$27.49▼$43.56$3.66B0.133,281 shs373 shsNPNYYNippon Yusen Kabushiki Kaisha$6.53-6.6%$6.79$5.40▼$7.58$15.05B1.1235,802 shs35,431 shsRNLSYRenault$10.65-1.1%$10.20$7.82▼$11.72$15.75B1.3534,110 shs18,207 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMXMFbioMérieux0.00%+0.20%+3.98%+9.17%+23.98%MAURYMarui Group-2.03%-5.57%+5.09%+25.12%+28.08%NPNYYNippon Yusen Kabushiki Kaisha-6.58%-0.65%-0.76%+4.31%+15.99%RNLSYRenault-1.11%+2.31%+5.25%+3.71%+7.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBMXMFbioMérieuxN/AN/AN/AN/AN/AN/AN/AN/AMAURYMarui GroupN/AN/AN/AN/AN/AN/AN/AN/ANPNYYNippon Yusen Kabushiki KaishaN/AN/AN/AN/AN/AN/AN/AN/ARNLSYRenaultN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMXMFbioMérieux 4.00Strong BuyN/AN/AMAURYMarui Group 0.00N/AN/AN/ANPNYYNippon Yusen Kabushiki Kaisha 0.00N/AN/AN/ARNLSYRenault 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest MAURY, BMXMF, RNLSY, and NPNYY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/25/2025RNLSYRenaultDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMXMFbioMérieux$3.98B3.90$5.80 per share22.58$34.31 per share3.82MAURYMarui Group$1.63B2.24$2.66 per share14.67$17.54 per share2.22NPNYYNippon Yusen Kabushiki Kaisha$16.54B0.91$0.77 per share8.46$8.49 per share0.77RNLSYRenault$60.85B0.26$4.07 per share2.62N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMXMFbioMérieux$387.03MN/A0.00∞N/AN/AN/AN/A5/15/2025 (Estimated)MAURYMarui Group$170.20M$1.8321.31∞N/A10.31%11.24%2.68%5/13/2025 (Estimated)NPNYYNippon Yusen Kabushiki Kaisha$1.51B$1.364.80∞N/A18.28%15.53%10.26%5/7/2025 (Estimated)RNLSYRenault$2.38BN/A0.003.76N/AN/AN/AN/AN/ALatest MAURY, BMXMF, RNLSY, and NPNYY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/13/2025Q3 2025MAURYMarui GroupN/A$0.53N/A$0.48N/A$418.97 million2/5/2025Q3 2025NPNYYNippon Yusen Kabushiki KaishaN/A$0.38N/A$0.38N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMXMFbioMérieuxN/AN/AN/AN/AN/AMAURYMarui Group$0.972.49%N/A53.01%N/ANPNYYNippon Yusen Kabushiki Kaisha$0.233.52%N/A16.91%N/ARNLSYRenault$0.292.72%N/AN/AN/ALatest MAURY, BMXMF, RNLSY, and NPNYY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025RNLSYRenault$0.33093.11%5/7/20255/8/20255/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMXMFbioMérieux0.102.211.20MAURYMarui Group1.872.332.33NPNYYNippon Yusen Kabushiki Kaisha0.221.251.14RNLSYRenaultN/A1.030.97Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMXMFbioMérieuxN/AMAURYMarui GroupN/ANPNYYNippon Yusen Kabushiki KaishaN/ARNLSYRenaultN/AInsider OwnershipCompanyInsider OwnershipBMXMFbioMérieuxN/AMAURYMarui GroupN/ANPNYYNippon Yusen Kabushiki KaishaN/ARNLSYRenaultN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMXMFbioMérieux14,600118.36 millionN/ANot OptionableMAURYMarui Group4,50093.73 millionN/ANot OptionableNPNYYNippon Yusen Kabushiki Kaisha35,2432.31 billionN/ANot OptionableRNLSYRenault106,0001.48 billionN/ANot OptionableMAURY, BMXMF, RNLSY, and NPNYY HeadlinesRecent News About These CompaniesRenault Boreal Name Revealed For Duster 7-SeaterApril 30 at 5:35 PM | rushlane.comHighlights of Renault Group's 2025 Annual General MeetingApril 30 at 5:35 PM | finance.yahoo.comRenault’s new Boreal to launch in 70 countriesApril 30 at 5:35 PM | cnbctv18.comRenault Boreal Name Reserved For 7-Seater Duster: DetailsApril 30 at 5:38 AM | ndtv.comRenault's new 7-seater SUV to be called the 'Boreal'April 30 at 5:38 AM | team-bhp.comRenault’s Boreal SUV Hides A Secret Under Its Fancy New NameApril 30 at 12:37 AM | carscoops.comRenault, Stellantis' Spain factories resume production after power outageApril 29 at 10:36 AM | reuters.comRenault price target lowered to EUR 47 from EUR 59 at Morgan StanleyApril 27, 2025 | markets.businessinsider.comRenault Group Champions Low-Carbon And Sustainable Mobility In European Automotive SectorApril 26, 2025 | drivespark.comRenault price target lowered to EUR 55 from EUR 60 at Deutsche BankApril 26, 2025 | markets.businessinsider.comRenault price target lowered to EUR 55 from EUR 64 at JPMorganApril 26, 2025 | markets.businessinsider.comRenault aims for more agility in India, reaffirms Nissan’s roleApril 25, 2025 | auto.economictimes.indiatimes.comFrench munitions firm Europlasma to take over former Renault foundryApril 25, 2025 | reuters.comRenault's new launches lift first quarter salesApril 25, 2025 | auto.economictimes.indiatimes.comRenault (0NQF) Gets a Buy from Berenberg BankApril 25, 2025 | markets.businessinsider.comRenault (0NQF) Gets a Hold from JefferiesApril 25, 2025 | markets.businessinsider.comNew Renault Duster Likely To Get Hybrid Powertrain In India: Powertrains To Be Shared With 7-Seater BigsterApril 25, 2025 | drivespark.comRenault Mulling Strong Hybrid For Duster, Bigster In India; No Mild HybridApril 25, 2025 | rushlane.comRenault Confirms Full-Year Outlook on Strong EV DemandApril 24, 2025 | livemint.comNew Renault Clio Goes Electric For Those Who Find The Retro 5 Too FunkyApril 24, 2025 | msn.comRenault SA (OTCMKTS:RNLSY) Short Interest Down 56.5% in MarchApril 18, 2025 | marketbeat.comMedia Sentiment Over TimeMAURY, BMXMF, RNLSY, and NPNYY Company DescriptionsbioMérieux OTCMKTS:BMXMF$131.01 0.00 (0.00%) As of 04/29/2025bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.Marui Group OTCMKTS:MAURY$39.00 -0.81 (-2.03%) As of 04/30/2025 12:13 PM EasternMarui Group Co., Ltd., an investment holding company, engages in the retailing and FinTech businesses in Japan. The company engages in the design and construction of commercial facilities; advertising planning and production; property management; rental of real estate properties; small-amount short-term insurance policy business; and sale of investment trusts. It is also involved in the operation of websites; contract store opening and operation services; provision of credit card services; operation of Marui/Modi stores; investing and financing direct-to-consumer businesses; internet sales; specialty store; credit loan; collection and management of receivables; credit check; trucking and forwarding; software development; and operation of IT systems, and building management businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.Nippon Yusen Kabushiki Kaisha OTCMKTS:NPNYY$6.53 -0.46 (-6.58%) As of 04/30/2025 03:58 PM EasternNippon Yusen Kabushiki Kaisha provides various logistics services worldwide. It operates through Liner & Logistics Business, Bulk Shipping Business, and Other Business segments. The company offers liner trading services, such as container shipping, and terminal and stevedoring services for containerships, car carriers, and cruise ships; and air cargo transportation services. It also provides bulk shipping services comprising transport services for finished automobiles, heavy construction machines, and used cars; transportation services for bulk freight, including iron ore, coal, and wood chips; and transportation services for crude oil, petroleum products, chemicals, liquefied petroleum gas, liquefied natural gas, and coal. In addition, the company is involved in the upstream areas of the supply chain for oil and natural gas. Further, it operates Asuka II, a luxury cruise ship; and manages commercial and residential buildings. Nippon Yusen Kabushiki Kaisha was incorporated in 1885 and is headquartered in Tokyo, Japan.Renault OTCMKTS:RNLSY$10.65 -0.12 (-1.11%) As of 04/30/2025 03:52 PM EasternRenault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. It also engages in the design and production of parts and equipment used for manufacturing and operation vehicles. The company operates through Automotive, Sale Financing, and Mobility Services segments. Its Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in Nissan. The company's Sale Financing segment offers sale financing, leasing, maintenance, and services contract under the Mobilize Financial Services brand. Its Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize brand. In addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles under the Renault, Dacia, Alpine, and Mobilize brands. Further, the company offers used vehicles and spare parts; and engages in business-to-business powertrain activities, and research and advanced engineering activities. Renault SA was founded in 1898 and is based in Boulogne-Billancourt, France. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
